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which begs the question why, instead of a single model including pertinent covariates the authors choose a multitude of models. Further, why is interaction testing no used, instead of applying models across different subgroups? The choice of covariates included in the final model is based on an usual cutoff (0.25 instead of the more common 0.1). However, the most pressing question is how were dynamic variables (such as BMI, HgA1c or meds) treated in the models -were they dynamically updated or was the baseline assessment used in the final models? This is crucial given that with advancing age, one would expect addition or worsening of comorbidities, and it is unclear how the authors addressed this issue.
4. Can the authors provide an information on the types of death? Again, this ties to the previous question regarding age on inclusion; types of death vary widely according to age and as such, it would be of interest to at least know which of these deaths were cardiovasculal vs not.
5. The tables are very challenging and at present uninformative. Multiple mistakes are noted throughout; for example, why is there a variable "Death" in the baseline characteristics table? Also, are these characteristics obtained at the first stage (study entry)? If so, the authors must demonstrate changes observed overtime (ie how many patients developed new conditions or had changed habits/socioeconomic status etc). In addition, some numbers are non sensical (see SBP and BMI reported mean/SD -presumablyin the columns. Table 2 is difficult to interpret and fraught with mistakes.
The figures are similarly uninformative; what is the purpose of demonstrating mortality according to age groups ? One would argue that a survival curve according to socioeconomic status or compliance with medications would be of more interest and closer to the most important association found in the study.
6. The discussion requires extensive editing -there are several sentences that are non-sensical (as an example, see page 12, 3rd paragraph, last sentence) and spelling mistakes are noted throughout. The authors repeat statements related to socioeconomic status which beckons the question why they did not primarily focus their analyses on these variables predominantly -despite that, the opening paragraph is fairly non-descript in terms of main findings. The question of BMI and association with long term mortality is an interesting one and deserves more attention in the discussion section.
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GENERAL COMMENTS
Present study examines the association between a range of sociodemogpraphic, lifestyle and metabolic factors with all-cause mortality in a Australian data with 4000 participants. Authors show that socioeconomic factors seem to be the most important predictors of all-cause mortality.
The major strength of the study is the good quality data and the long-follow time (over 18 years). However, there are some issues that should be addressed. , with a total follow up of up to 18 years. Data collection was based on questionnaire collection at baseline as well as in clinic with further clinic follow up (or communication via phone call) every 4-5 years. In the present report, subjects with less than 2 yr follow up were excluded and the main outcome was all-cause mortality as reported in local registries and hospitals.
The authors are congratulated for a fairly consistent follow up of a well defined population with minor mobility in and out of the specific region, as well as the long term data collected. Nevertheless, there are several major concerns with the presented report:  We thank you for the positive comments. We addressed your comments/concerns accordingly as follows.
1. The main hypothesis is very vague; the authors attempt to exploit several collected variables and provide insight into the relevant contribution of each factor on long-term mortality. However, this significantly undermines the key points of the specific cohort study and introduces several levels of inclusion bias. The number of events and extremely wide age range of participants certainly does not allow for multiple levels of subanalyses. I strongly encourage the authors to better define their hypothesis and avoid analyses that only weaken the overall presentation.  This analysis is explorative. Therefore, we hypothesized that of all known risk factors for mortality, there are likely to be more relevant predictors in this community-based cohort study (we highlighted this in the "Introduction"). Considering all potential predictors of mortality would provide adjusted estimates of association between a predictor and mortality. As such, we decided to approach the analysis using the all potential predictors we have in the data. We believe that considering all level of risk factors (from such a unique cohort) to estimate the relative importance of predictors and identify the most important risk factors (clusters of risk factors) of all-cause mortality is an imperative step.  Similar analysis has been conducted in previous studies (Ganna A, Ingelsson E. 5 year mortality predictors in 498,103 UK Biobank participants: a prospective population-based study. Lancet (London, England). 2015; 386(9993):533-40 .)  We are aware of the wide range of age in our cohort. Thus, we conducted a stratified analysis and presented the results (see Supplementary Tables 5 and 6 ). In addition to risk factors in the general population, the subgroup analysis provided further insight regarding the predictors of risk factors by age group. The subgroup models were well fitted (converged) as we had sufficient events. For instance, the 121 and 311 deaths that occurred in those <65 and ≥65 years of age which were enough to perform the subgroup analysis. These subgroup analyses are important complementary analyses for the overall analysis, providing supporting evidence in specific population groups. This was clearly the case for some variables such as BMI, where we found higher BMI associated with lower mortality in those 65 years and over compared with those less than 65 years. 2. The authors fail to specifically report on the methodology of cohort follow up; it is of extreme importance in such studies to be more specific as to how data were collected rather than reference a prior report. Similarly, the age range is barely mentioned and we are left wondering the age distribution of the specific cohort.  We provided the mean (SD) of the population -50.4 (16.9) years. In the current draft, we also include age ranges to give an idea of age distribution for readers (min=18 years; max=90 years). The following histogram depicts the age distribution of our cohort at the baseline  Regarding the method, we provided a brief highlight with pertinent information about the cohort study (regarding recruitment, stages of study, data collection methods, sample size, place of study……) in the second paragraph of "Study design and population" section. In the same paragraph, we also describe which stage of the data we used: "All covariates used in this study were collected at Stage 1."
 We focused on pertinent methods given the word limit of the journal. 3. The methodology, though somehow described, follows the same pattern as the hypothesis.
Multiple models are introduced, which begs the question why, instead of a single model including pertinent covariates the authors choose a multitude of models.
 In these models, we are able to explore the confounding effects of one cluster of variables (e. However, the most pressing question is how were dynamic variables (such as BMI, HgA1c or meds) treated in the models -were they dynamically updated or was the baseline assessment used in the final models? This is crucial given that with advancing age, one would expect addition or worsening of comorbidities, and it is unclear how the authors addressed this issue.  Thank you for mentioning this as it is an important methodological issue. As stated under "Methods", we did not use time varying covariates rather we used the baseline characteristics of participants. In the second paragraph of "Study design and population" section, we also mentioned which stage of the data was used: "All covariates used in this study were collected at Stage 1."  We did not use time varying covariates because of high attrition rate between Stage 1 and Stages 2 and 3. In addition, some of the variables were measured using different approaches (example: physical activity). Further, cumulative missing values of variables across stages would have substantially reduced the sample size if we used data of all the three stages.  We described this as a limitation in the discussion. "….Thirdly, there could be changes in participants' characteristics after the baseline data collection. We were not able to take an account of these changes….." 4. Can the authors provide an information on the types of death? Again, this ties to the previous question regarding age on inclusion; types of death vary widely according to age and as such, it would be of interest to at least know which of these deaths were cardiovasculal vs not.  This is a valid point, thank you. We have the data on cause of death. However, we were not interested to perform analysis on cause-specific deaths and their predictors for two main reasons: 1. We have incomplete data on cause of death.  The available dataset shows that 153/637 (24%) of deaths are caused by CVD. Cancer caused 29.4% of deaths. However, we do not have cause of death for other deaths (n=297).  We know that 90% of deaths in high-income countries are due to non-communicable chronic diseases (NCDs). In Australia, 91% of all deaths are due to NCDs. Of all deaths in Australia, 31% are caused by cardiovascular disease with which our rate of 24% is comparable.
(https://vizhub.healthdata.org/gbd-compare/). 2. Notification of cause of death in Australia is usually completed by general practitioners and inaccuracies in coding are common. 5. The tables are very challenging and at present uninformative. Multiple mistakes are noted throughout; for example, why is there a variable "Death" in the baseline characteristics table?
 We made corrections on all Tables. We removed death from Table 1 .  Tables that depict association estimates have four models. These models are described in the footnotes. In general, model 1 is adjusted for sociodemographic factors; model 2 = model + behavioral factors; model 3 = model 2 + metabolic factors; model 4 = model 3 + health status, medication and health service utilization.  Therefore, model 4 is the most adjusted model. This approach helps to systematically identify the most important predictor and confounding factors in predicting the outcome. Also, are these characteristics obtained at the first stage (study entry)?
 Yes. This is specified on the title of the table. If so, the authors must demonstrate changes observed overtime (ie how many patients developed new conditions or had changed habits/socioeconomic status etc). In addition, some numbers are non sensical (see SBP and BMI reported mean/SD -presumably-in the columns.
 We did not include data from Stage 2 and 3 for the above-mentioned reasons (i.e. high number of attrition and different data collection methods of covariates at each stage) Table 2 is difficult to interpret and fraught with mistakes.
 Thank you for identifying this issue. In the current version, we corrected the mistakes we were able to identify.
The figures are similarly uninformative; what is the purpose of demonstrating mortality according to age groups? One would argue that a survival curve according to socioeconomic status or compliance with medications would be of more interest and closer to the most important association found in the study.  We removed the figure with age and replaced with income level as we observed a consistent association between income and mortality. The other three variables (sex, diabetes status and area of residency) are also important predictors. So, we retained these in the belief that KM graphs according to these important variables provide important information. 6. The discussion requires extensive editing -there are several sentences that are non-sensical (as an example, see page 12, 3rd paragraph, last sentence) and spelling mistakes are noted throughout. The authors repeat statements related to socioeconomic status which beckons the question why they did not primarily focus their analyses on these variables predominantly -despite that, the opening paragraph is fairly non-descript in terms of main findings.  Thank you. We have made substantial amendments to the Discussion based on your helpful comments. The question of BMI and association with long term mortality is an interesting one and deserves more attention in the discussion section.
 Thank you. We added the following statement which we think is important to make in the current version of the paper. "Further, improved treatments for diseases, particularly for cardiovascular diseases, may have greater effect at higher BMI."  Further points are mentioned in response to similar comments made by reviewer 2 Please see below. Reviewer: 2 Reviewer Name: Christian Hakulinen, Post-doctoral researcher Institution and Country: University of Helsinki, Finland Please state any competing interests or state 'None declared': None declared Please leave your comments for the authors below  Present study examines the association between a range of sociodemogpraphic, lifestyle and metabolic factors with all-cause mortality in a Australian data with 4000 participants. Authors show that socioeconomic factors seem to be the most important predictors of all-cause mortality. The major strength of the study is the good quality data and the long-follow time (over 18 years). However, there are some issues that should be addressed.  Thank you for your positive comment.  My main concern is that there are problems related to the analytical model. First of all, many predictors are likely highly correlated, but it is unclear how this was dealt with. Second, authors say that predictors from the univariate model with a p-value less than .25 were included in the multivariate model. To me, this seems very liberal.
 We have provided the correlation coefficients in the supplement table (Supplementary  Table 7) . From the Table 7 ). The results suggest that collinearity of covariates is in fact not confirmed.  Relating to the presentation of the results, what was the rationale for presenting survival curves also for diabetes in addition to sex, age and region?  These variables are important predictors in our models. In the revised version (and in response to comments from reviewer 1), we have included income as we found that to be an important predictor.  Introduction is well written, but authors seemed to have miss an important paper on the topic (Ganna & Ingelsson, 2015. Lancet) , where multiple predictors of mortality where examined in the UK Biobank data. Moreover, another recent study from the UK Biobank suggest that most of the excess mortality related to psychosocial factors is likely explained by other risk factors (see: Elovainio et al., 2017. Lancet Public Health), indicating that there are multiple pathways from psychosocial factors to mortality.  Thank you. We have incorporated these papers in the current version of the manuscript.  As it has been consistently shown that both obesity and overweight are related to higher allcause mortality (Lancet 2016) , what could possible explain the present finding that overweight is protective?  We acknowledge that there are studies showing that overweight and obesity are associated with increased risk of mortality. On the other hand, evidence shown that the BMI associated with the lowest all-cause mortality has increased. For instance, a Danish study that included participants between 20 and 100 years of age showed that the BMI associated with the lowest all-cause mortality increased by 3.3 kg/m 2 from cohorts enrolled from 1976 -1978 through 2003 -2013 (Afzal S, Change in Body Mass Index Associated With Lowest Mortality in Denmark, 1976 -2013 . JAMA 2016 . In a meta-analysis, it was demonstrated that, for older populations, being overweight was not found to be associated with an increased risk of mortality (Winter JE, BMI and allcause mortality in older adults: a meta-analysis; AJCN 2014) . A study also showed that higher BMI (higher than 25 kg/m2) in older people is associated with lowest risk of mortality in 2.6 million people in UK (Bhaskaran K. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK. The lancet Diabetes & endocrinology. 2018; 6(12) :944-53.)  There could be several reasons for this. Some of these are mentioned below (all of these reasons are discussed in the manuscript):  While improved treatment for cardiovascular risk factors or complicating diseases has reduced mortality in all weight classes, the effects may have been greater at higher BMI levels than at lower BMI levels. (Gregg EW, Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005; 293(15):1868 -1874 ).  People who had normal BMI may have experienced a reduction in BMI from overweight/obese as a consequence of pre-existing disease that subsequently lead to death. However, as we adjusted for disease condition in our analysis this would seem to be an unlikely explanation.
